Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-07 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0004 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |